Stage IV Lung Cancer AJCC v6
|
disease |
|
Neoplastic Process
|
7
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Hemangiosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
162
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
1992 |
1992 |
Treatment related secondary malignancy
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
462
|
79
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
Polymorphous low grade adenocarcinoma
|
disease |
|
Neoplastic Process
|
23
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Blood Vessel Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.010 |
None |
< 0.001 |
1 |
|
2007 |
2007 |
Thyroid Diseases
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
230
|
26
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Vitamin D Deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
153
|
37
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Diabetes Insipidus
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
57
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Osteosarcoma recurrent
|
disease |
Neoplasms
|
Neoplastic Process
|
3
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Metaplastic squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Mesothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
560
|
4
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
10
|
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
EPILEPSY, PYRIDOXINE-DEPENDENT
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
25
|
26
|
0.010 |
None |
< 0.001 |
1 |
|
2004 |
2004 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.030 |
None |
0.333 |
3 |
|
2001 |
2004 |
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
733
|
197
|
0.020 |
None |
0.500 |
2 |
|
2006 |
2009 |
HER-2 protein overexpression
|
disease |
|
Disease or Syndrome
|
4
|
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2016 |
Cutaneous Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
507
|
248
|
0.110 |
None |
0.500 |
2 |
3
|
2001 |
2016 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.020 |
None |
0.500 |
2 |
|
2004 |
2016 |
Small intestine carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
17
|
1
|
0.020 |
None |
0.500 |
2 |
|
2013 |
2019 |
Premenopausal breast cancer
|
disease |
|
Neoplastic Process
|
51
|
18
|
0.020 |
None |
0.500 |
2 |
|
2018 |
2018 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.020 |
None |
0.500 |
2 |
|
1999 |
2001 |
Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1096
|
261
|
0.020 |
None |
0.500 |
2 |
|
2004 |
2016 |
Acute lymphocytic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1293
|
222
|
0.020 |
None |
0.500 |
2 |
|
2004 |
2016 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.020 |
None |
0.500 |
2 |
|
1990 |
2009 |